Influence of obesity on pharmacokinetics and pharmacodynamics of isoflurane.
- Author:
Zhi-yi GONG
1
;
Tie-hu YE
;
Yi-dan HUANG
;
Nuo-er SANG
;
He DUAN
;
Hong-zhi REN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Anesthesia, Inhalation; Anesthetics, Inhalation; administration & dosage; pharmacokinetics; Body Mass Index; Cholecystectomy, Laparoscopic; Dose-Response Relationship, Drug; Female; Humans; Isoflurane; administration & dosage; pharmacokinetics; Male; Middle Aged; Obesity; complications; metabolism
- From: Acta Academiae Medicinae Sinicae 2003;25(5):615-618
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the effect of obesity on pharmacokinetics and pharmacodynamics of isoflurane.
METHODSTwenty-six patients undergoing cholecystectomy were divided into obese group (Group A, BMI > or = 27, n = 13) and normal body weight group (Group N, BMI < or = 24, n = 13) according to body mass index (BMI). All patients were given to the same isoflurane anesthesia. Inspired and end-expired concentrations of isoflurane were monitored and uptake fraction of isoflurane were calculated.
RESULTSIsoflurane concentrations of vaporizer in Group A [(1.8 +/- 0.3)%] were evidently higher than those in Group N [(1.5 +/- 0.1)%] at all observed points (P < 0.05 or P < 0.01). Uptake fraction of isoflurane in Group A were higher than those in Group N at observed points (P < 0.05, P < 0.01 or P < 0.001), but there were no differences in the time when isoflurane concentration was lowered to 50% and awake time between the two groups after discontinuing inhaling isoflurane.
CONCLUSIONSObese patients demand higher inspired concentration and uptake of isoflurane than those in normal weight patients but discharge of isoflurane was influenced by obesity within the observed period of (66 +/- 33) min.
